OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · IEX Real-Time Price · USD
10.70
0.00 (0.00%)
Jul 26, 2024, 4:00 PM EDT - Market closed

OptimizeRx Revenue

OptimizeRx had revenue of $19.69M in the quarter ending March 31, 2024, with 51.43% growth. This brings the company's revenue in the last twelve months to $78.21M, up 26.71% year-over-year. In the year 2023, OptimizeRx had annual revenue of $71.52M with 14.53% growth.

Revenue (ttm)
$78.21M
Revenue Growth
+26.71%
P/S Ratio
2.50
Revenue / Employee
$575,063
Employees
136
Market Cap
195.49M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202371.52M9.07M14.53%
Dec 31, 202262.45M1.16M1.89%
Dec 31, 202161.29M17.98M41.51%
Dec 31, 202043.31M18.72M76.08%
Dec 31, 201924.60M3.39M15.99%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Coherus BioSciences 301.87M
Rigel Pharmaceuticals 120.35M
Biodesix 54.85M
908 Devices 50.73M
Fennec Pharmaceuticals 44.95M
MediWound 19.85M
Fractyl Health 148.00K
Revenue Rankings